Get started
Author

Louise Ambler-Osborn

Observed names: Ambler-Osborn, Louise, LOUISE AMBLER-OSBORN
OpenAlex ID: A5041323058
Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice
2022 · Moshe Phillip, Revital Nimri, et al. · Endocrine Reviews · 439
PDF
Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes
2021 · Sue A. Brown, Gregory P. Forlenza, et al. · Diabetes Care · 285
PDF
Closed-Loop Insulin Therapy Improves Glycemic Control in Adolescents and Young Adults: Outcomes from the International Diabetes Closed-Loop Trial
2020 · Elvira Isganaitis, Dan Raghinaru, et al. · Diabetes Technology & Therapeutics · 114
Safety and Glycemic Outcomes With a Tubeless Automated Insulin Delivery System in Very Young Children With Type 1 Diabetes: A Single-Arm Multicenter Clinical Trial
2022 · Jennifer L. Sherr, Bruce W. Bode, et al. · Diabetes Care · 97
PDF
A Randomized Clinical Trial Assessing Continuous Glucose Monitoring (CGM) Use With Standardized Education With or Without a Family Behavioral Intervention Compared With Fingerstick Blood Glucose Monitoring in Very Young Children With Type 1 Diabetes
2020 · Strategies to Enhance New CGM Use in Early Childhood (SENCE) Study Group, Lori Laffel, et al. · Diabetes Care · 94
PDF
Longitudinal Changes in Continuous Glucose Monitoring Use Among Individuals With Type 1 Diabetes: International Comparison in the German and Austrian DPV and U.S. T1D Exchange Registries
2019 · Kellee M. Miller, Julia Hermann, et al. · Diabetes Care · 92
The Contemporary Prevalence of Diabetic Neuropathy in Type 1 Diabetes: Findings From the T1D Exchange
2020 · Kara R. Mizokami-Stout, Zoey Li, et al. · Diabetes Care · 88
Patient-Reported Outcomes in a Randomized Trial of Closed-Loop Control: The Pivotal International Diabetes Closed-Loop Trial
2021 · Yogish C. Kudva, Lori M. Laffel, et al. · Diabetes Technology & Therapeutics · 68
Randomized Controlled Trial of Mobile Closed-Loop Control
2020 · Boris Kovatchev, Stacey M. Anderson, et al. · Diabetes Care · 60
Glycemic Outcomes of Use of CLC Versus PLGS in Type 1 Diabetes: A Randomized Controlled Trial
2020 · Sue A. Brown, Roy W. Beck, et al. · Diabetes Care · 55
Efficacy and Safety of a Tubeless AID System Compared With Pump Therapy With CGM in the Treatment of Type 1 Diabetes in Adults With Suboptimal Glycemia: A Randomized, Parallel-Group Clinical Trial
2024 · Eric Renard, Ruth S. Weinstock, et al. · Diabetes Care · 40
PDF
A Comparison of Postprandial Glucose Control in the Medtronic Advanced Hybrid Closed-Loop System Versus 670G
2022 · Stuart A. Weinzimer, Ryan J. Bailey, et al. · Diabetes Technology & Therapeutics · 22
Clinical Management and Pump Parameter Adjustment of the Control-IQ Closed-Loop Control System: Results from a 6-Month, Multicenter, Randomized Clinical Trial
2020 · Grenye O'Malley, Laurel H. Messer, et al. · Diabetes Technology & Therapeutics · 22
Insulin Delivery and Glucose Variability Throughout the Menstrual Cycle on Closed Loop Control for Women with Type 1 Diabetes
2022 · Carol J. Levy, Grenye O'Malley, et al. · Diabetes Technology & Therapeutics · 21
Outpatient Randomized Crossover Comparison of Zone Model Predictive Control Automated Insulin Delivery with Weekly Data Driven Adaptation Versus Sensor-Augmented Pump: Results from the International Diabetes Closed-Loop Trial 4
2022 · Jordan E. Pinsker, Eyal Dassau, et al. · Diabetes Technology & Therapeutics · 18
INHALE-1: A Multicenter Randomized Trial of Inhaled Technosphere Insulin in Children With Type 1 Diabetes
2025 · Michael J. Haller, Lauren Kanapka, et al. · Diabetes Care · 9
PDF
Use of the Omnipod 5 Automated Insulin Delivery System Activity Feature Reduces Insulin Delivery and Attenuates the Drop in Glycemia Associated With Exercise in a Randomized Controlled Trial
2025 · Lauren V. Turner, Jennifer L. Sherr, et al. · Diabetes Care · 7
PDF
Improvement in Mean CGM Glucose in Young People with Type 1 Diabetes During 1 Year of the COVID-19 Pandemic
2021 · Tara Kaushal, Liane Tinsley, et al. · Diabetes Technology & Therapeutics · 7
Rapid Adoption of Telemedicine Along with Emergent Use of Continuous Glucose Monitors in the Ambulatory Care of Young Persons with New-Onset Type 1 Diabetes in the Time of COVID-19: A Case Series
2021 · Tara Kaushal, Louise Ambler-Osborn, et al. · Telemedicine Journal and e-Health · 6
Glycemic Outcomes of Use of CLC vs PLGS in Type 1 Diabetes: A Randomized, Controlled Trial
2020 · Sue A. Brown, Roy W. Beck, et al. · 1
Glycemic Outcomes of Use of CLC vs PLGS in Type 1 Diabetes: A Randomized, Controlled Trial
2020 · Sue A. Brown, Roy W. Beck, et al. · 1
Erratum. Use of the Omnipod 5 Automated Insulin Delivery System Activity Feature Reduces Insulin Delivery and Attenuates the Drop in Glycemia Associated With Exercise in a Randomized Controlled Trial. Diabetes Care 2025;48:1598–1606
2025 · Lauren V. Turner, Jennifer L. Sherr, et al. · Diabetes Care
PDF
935-P: Favorable Shift in CGM Glucose in Youth with T1D during COVID-19 Pandemic
2021 · TARA KAUSHAL, LIANE J. TINSLEY, et al. · Diabetes
Works count: 26
Citation count: 1,634
H-index: 17
I10-index: 18
Year
Topic
Type